Clinical Trial Update: Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD) [NA]

View source ↗

Summary

A terminated clinical trial investigating imaginal exposure with D-cycloserine for posttraumatic stress disorder; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Posttraumatic Stress Disorder | NA | Status: TERMINATED | Results posted: 2021-08-16